ENDV · Endonovo Therapeutics, Inc. · Documents
$0.00
At close · Sep 16
Going-concern doubt
— flagged Dec 29, 2023
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt as to its ability to continue as going concern within one year from issuance date of these unaudited consolidated financial statements.”View the 10-Q filed Dec 29, 2023
Market Cap
$31,875
Shares
318.75M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2024-01-03 | 2023-12-29 | |
| 10-Q/A | 2023-12-29 | 2023-09-30 | |
| 10-Q | 2023-12-29 | 2023-09-30 | |
| 8-K | 2023-12-04 | — | |
| 8-K | 2023-10-12 | 2023-10-05 | |
| 10-Q | 2023-08-21 | 2023-06-30 | |
| 10-Q | 2023-05-22 | 2023-03-31 | |
| 10-K | 2023-04-17 | 2022-12-31 | |
| 8-K | 2023-03-29 | 2023-03-28 | |
| 10-Q | 2022-11-21 | 2022-09-30 | |
| 8-K | 2022-09-27 | 2022-09-26 | |
| 10-Q | 2022-08-22 | 2022-06-30 | |
| 10-Q | 2022-05-19 | 2022-03-31 | |
| 10-K | 2022-04-14 | 2021-12-31 | |
| 10-Q | 2021-11-19 | 2021-09-30 | |
| 10-Q | 2021-08-23 | 2021-06-30 | |
| 10-Q | 2021-05-24 | 2021-03-31 | |
| 10-K | 2021-04-13 | 2020-12-31 | |
| 10-Q | 2020-11-19 | 2020-09-30 | |
| 10-Q | 2020-08-19 | 2020-06-30 | |
| 8-K | 2020-08-07 | 2020-08-06 | |
| 10-Q | 2020-06-12 | 2020-03-31 | |
| 8-K | 2020-05-26 | 2020-05-20 | |
| 8-K | 2020-05-19 | — | |
| 10-K | 2020-05-04 | 2019-12-31 | |
| 8-K | 2020-04-10 | — | |
| 8-K | 2020-03-02 | — | |
| 8-K | 2020-02-03 | 2020-01-29 |
Showing 1–28 of 28 filings